Literature DB >> 14982490

Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells.

B Marples1, B G Wouters, S J Collis, A J Chalmers, M C Joiner.   

Abstract

This review highlights the phenomenon of low-dose hyper- radiosensitivity (HRS), an effect in which cells die from excessive sensitivity to small single doses of ionizing radiation but become more resistant (per unit dose) to larger single doses. Established and new data pertaining to HRS are discussed with respect to its possible underlying molecular mechanisms. To explain HRS, a three-component model is proposed that consists of damage recognition, signal transduction and damage repair. The foundation of the model is a rapidly occurring dose-dependent pre-mitotic cell cycle checkpoint that is specific to cells irradiated in the G2phase. This checkpoint exhibits a dose expression profile that is identical to the cell survival pattern that characterizes HRS and is probably the key control element of low-dose radiosensitivity. This premise is strengthened by the recent observation coupling low- dose radiosensitivity of G2-phase cells directly to HRS. The putative role of known damage response factors such as ATM, PARP, H2AX, 53BP1 and HDAC4 is also included within the framework of the HRS model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982490     DOI: 10.1667/rr3130

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  54 in total

Review 1.  Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.

Authors:  Anish Prasanna; Mansoor M Ahmed; Mohammed Mohiuddin; C Norman Coleman
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Cytogenetic effects of low-dose radiation with different LET in human peripheral blood lymphocytes.

Authors:  E A Nasonova; N L Shmakova; O V Komova; L A Mel'nikova; T A Fadeeva; E A Krasavin; S Ritter
Journal:  Radiat Environ Biophys       Date:  2006-10-10       Impact factor: 1.925

3.  Recent reports on the effect of low doses of ionizing radiation and its dose-effect relationship.

Authors:  M Tubiana; A Aurengo; D Averbeck; R Masse
Journal:  Radiat Environ Biophys       Date:  2006-02-09       Impact factor: 1.925

4.  LNT: a never-ending story.

Authors:  Anna A Friedl; Werner Rühm
Journal:  Radiat Environ Biophys       Date:  2006-03       Impact factor: 1.925

5.  Low dose hyper-radiosensitivity in human lung cancer cell line A549 and its possible mechanisms.

Authors:  Xiaofang Dai; Dan Tao; Hongge Wu; Jing Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

6.  Non-problematic risks from low-dose radiation-induced DNA damage clusters.

Authors:  Daniel P Hayes
Journal:  Dose Response       Date:  2008-01-16       Impact factor: 2.658

7.  Nonlinear response for neoplastic transformation following low doses of low let radiation.

Authors:  J Leslie Redpath
Journal:  Nonlinearity Biol Toxicol Med       Date:  2005-01

8.  Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological origin.

Authors:  Kaoru Takabayashi; Kazuhiro Kashiwagi; Tetsuya Kawata; Toshiro Sato; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Hiromasa Takaishi; Toshifumi Hibi; Haruhiko Ogata; Naohisa Yahagi; Yuko Kitagawa; Naoyuki Shigematsu; Takanori Kanai
Journal:  Cancer Biol Ther       Date:  2013-10-22       Impact factor: 4.742

9.  Association of ATM activation and DNA repair with induced radioresistance after low-dose irradiation.

Authors:  L Enns; A Rasouli-Nia; M Hendzel; B Marples; M Weinfeld
Journal:  Radiat Prot Dosimetry       Date:  2015-04-22       Impact factor: 0.972

10.  Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study.

Authors:  Chaim B Colen; Navid Seraji-Bozorgzad; Brian Marples; Matthew P Galloway; Andrew E Sloan; Saroj P Mathupala
Journal:  Neurosurgery       Date:  2006-12       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.